praxismedicines.com - PRAX Korxona qiymati/daromad multiplikatori

praxismedicines.com (PRAX) - korporativ logo

Praxis Precision Medicines (PRAX) epilepsiyaning yangi davolash usullarini sinovdan o'tkazayotgan bir paytda jalb qilingan investitsiyalarga tayanadi. Yuqori R&D xarajatlari va FDA nazorati bozorga kirish uchun jiddiy to'siqlarni yaratadi. Korxonaning qiymatining daromadga nisbati ko'rsatkichi manipulyatsiyalarsiz barqarorlikni namoyish etadi, bunda 0.00 qiymati joriy darajani tavsiflaydi. Biroq, geosiyosiy to'lqinlar komponentlar yetkazib berishni buzishi va xalqaro tadqiqotlarni to'sib qo'yishi mumkin.

Praxis Precision Medicines (PRAX) EV/Sales multiplikatori: 23.11.2025 - 20.11.2026 davri uchun

Praxis Corp - tahliliy kesimlar va asosiy koʻrsatkichlar (PRAX)

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning dastlabki tahlili:PRAX, praxismedicines.com
Praxis Medicines original mahsuloti

EV/Sales ko'rsatkichi biznesning korxona qiymatini, jumladan sof qarzdorlikni, savdo hajmi bilan nisbatda belgilaydi. Investorlar ushbu koeffitsiyentdan qarz yuklamalarining buzilishlarisiz aktivlarni monetizatsiya qilish samaradorligini baholash uchun foydalanadilar. Praxis Precision Medicines (PRAX) kompaniyasining qarzdorlikni hisobga olmagan holda, tushumga asoslangan joriy baholanishi 0.00 ni tashkil etadi. Grafikning barqarorligi robotlashtirilgan molekulyar bioskriningga bo'lgan bozor ishonchini tasdiqlaydi. AI yordamida neyrodori vositalarini kashf qilishni avtomatlashtirish Praxis Precision Medicines (PRAX) kompaniyasining uzoq muddatli kapitalizatsiya o'sishi uchun asos yaratadi.

Raqobatchilar tahlili

BIIB (Biogen Inc.) - Kompaniya qiymati va daromad nisbati|NBIX: EV/Sales multiplikatori|RGC (Regencell Bioscience Holdings Limited) - Korxona qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Axsome Therapeutics Inc|ACAD: Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori XENE|EV/Sales multiplikatori vikingtherapeutics.com (VKTX)|Korxona qiymatining daromadga nisbati Supernus SUPN|Biznes qiymatining daromadga nisbati CPRX|denalitherapeutics.com - EV/Sales multiplikatori|Kompaniya umumiy qiymatining daromadga nisbati Harmony Pharma HRMY|BHVN: EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Anavex AVXL|Korxona qiymatining daromadga nisbati CeriBell Corp (CBLL)|Korxona qiymati/daromad koeffitsiyenti PRTA|EV/Sales multiplikatori ALEC (Alector)|Annexon (ANNX) - Korxona qiymati/daromad multiplikatori|OMER - Korxona qiymatining daromadga nisbati|NGNE (Neurogene) - Kompaniya qiymati va daromad nisbati|ACIU: EV/Sales multiplikatori|VYGR - Kompaniya umumiy qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Neumora Therapeutics, Inc.|Kompaniya qiymati va daromad nisbati SCLX (Scilex)|Kompaniya qiymatining daromadga nisbati TVGN (Tevogen Bio)|EV/Sales multiplikatori Alpha Cognition Inc (ACOG)|EV/Sales multiplikatori CGTX (cogrx.com)|Kompaniya umumiy qiymatining daromadga nisbati Inhibikase Pharma (IKT)|SAVA: Kompaniya qiymatining daromadga nisbati|Kompaniya umumiy qiymatining daromadga nisbati Assertio ASRT|COYA (coyatherapeutics.com) - Kompaniya qiymatining daromadga nisbati|Kompaniya qiymati va daromad nisbati VTGN|OVID (Ovid Therapeutics) - EV/Sales multiplikatori|Acumen Pharmaceuticals, Inc (ABOS) - Kompaniya umumiy qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati CervoMed, Inc. (CRVO)|ATHE - Korxona qiymati/daromad multiplikatori|EV/Sales multiplikatori CLNN (Clene Inc.)|Kompaniya umumiy qiymatining daromadga nisbati PepGen Inc. (PEPG)|JUNS - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Relmada Corp|ANVS (Annovis Bio, Inc.) - Kompaniya qiymatining daromadga nisbati|Grace Tx (GRCE) - EV/Sales multiplikatori|Kompaniya qiymatining daromadga nisbati AIFF|EV/Sales multiplikatori anewmeds.com|Korxona qiymatining daromadga nisbati NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Biznes qiymatining daromadga nisbati|MetaVia - Kompaniya qiymatining daromadga nisbati|NRXS: Kompaniya qiymati va daromad nisbati|Helius Medical Technologies, Inc. - EV/Sales multiplikatori|PASG: Korxona qiymatining daromadga nisbati|Neuphoria (NEUP) - Korxona qiymatining daromadga nisbati|Minerva Neurosciences - Biznes qiymatining daromadga nisbati|ATHA (Athira Pharma, Inc.) - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori addextherapeutics.com ADXN|Kompaniya qiymatining daromadga nisbati ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori PTIX (Protagenic)|EV/Sales multiplikatori pasitheaclinics.com KTTA|CRGT - Korxona qiymatining daromadga nisbati|Biznes qiymatining daromadga nisbati ATXI (Avenue Therapeutics)|BCLI: EV/Sales multiplikatori|Cara Therapeutics - Biznes qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Chromocell Therapeutics Corporation|EV/Sales multiplikatori Eliem Therapeutics Inc.|Korxona qiymatining daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori MRNS (marinuspharma.com)|NKGN: Kompaniya qiymati va daromad nisbati|NRBO - Korxona qiymatining daromadga nisbati|SAGE - EV/Sales multiplikatori|Synaptogenix (SNPX) - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Trevena (TRVN)|Kompaniya qiymatining daromadga nisbati VIGL|Kompaniya qiymati va daromad nisbati WENA (Anew Medical)|EV/Sales multiplikatori CERE